TherapeuticsMD (TXMD) Receivables - Other (2012 - 2026)

TherapeuticsMD's Receivables - Other history runs 8 years deep, the most recent figure standing at $3.2 million for Q1 2026.

• Quarterly Receivables - Other rose 7.18% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (up 7.18% YoY) and the FY2025 annual result came in at $3.5 million, down 1.04% from the prior year.
• Receivables - Other was $3.2 million for Q1 2026 at TherapeuticsMD, down from $3.5 million in the prior quarter.
• Across five years, Receivables - Other topped out at $3.7 million in Q2 2025 and bottomed at $2.9 million in Q2 2024.
• A 4-year average of $3.3 million and a median of $3.3 million in 2024 frame the typical range for Receivables - Other.
• Peak annual rise in Receivables - Other reached 28.71% in 2025, while the deepest fall reached 7.01% in 2025.
• TherapeuticsMD's Receivables - Other stood at $3.1 million in 2023, then grew by 15.28% to $3.6 million in 2024, then slipped by 1.04% to $3.5 million in 2025, then fell by 8.91% to $3.2 million in 2026.
• Business Quant data shows TXMD's Receivables - Other at $3.2 million in Q1 2026, $3.5 million in Q4 2025, and $3.7 million in Q3 2025.